Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0282612 (
PIN
)
2,291
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The expression of cytokeratin (CK) mRNA for CK5, -8, -14, -16, and -19 was investigated in normal prostate,
prostatic intraepithelial neoplasia
(
PIN
) lesions, and invasive carcinoma using in situ hybridization. Protein localization was carried out in adjacent sections using immunohistochemistry and correlated with mRNA expression. Snap-frozen human prostate samples including 22 examples of normal glands, 20 cases of
PIN
lesions, and 12 cases of invasive carcinoma were examined. CK5 and -14 mRNA and protein were prominently expressed only in the basal cells of normal glands and
PIN
lesions. CK14 mRNA was absent in the luminal cells of the most of the
PIN
lesions but was seen at a low level in some
PIN
lesions. CK14 protein was not detected in any
PIN
lesion, suggesting that, if the cell that makes up the
PIN
lesions is derived from a basal cell, CK14 translation is depressed although a low level of CK14 mRNA may persist. CK8 mRNA and protein were constitutively expressed in all epithelia of normal and abnormal prostate tissues. CK19 mRNA and protein were persistently expressed in both basal and luminal cells of the tubular portion of normal glands as well as
PIN
lesions, but were expressed heterogeneously in both basal and luminal cells of normal alveoli.
CK16
mRNA was expressed in a similar pattern as CK19, but
CK16
protein was not detected either in normal or in abnormal prostate tissues. In conclusion, the expression of CK19 in
PIN
lesions is similar to its tubular expression and would support an origin of
PIN
lesions from this structure rather than the alveolar portion of the glands. The similar cytokeratin expression between
PIN
lesions and invasive carcinoma further supports the concept that
PIN
is a precursor lesion of invasive carcinoma.
...
PMID:Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma. 903 82